期刊文献+

妇肤康喷雾剂治疗混合性阴道感染的临床研究 被引量:6

Clinical study of Fufukang spray treatment for mixed vaginal infections
下载PDF
导出
摘要 目的:观察分析妇肤康喷雾剂治疗混合性阴道感染的临床疗效。方法:选取从2009年6月至2014年6月收治的混合性阴道感染患者共140例。随机将患者分为观察组和对照组,其中观察组患者采用妇肤康喷雾剂联合制霉素治疗,对照组患者则采用常规甲硝唑和制霉素治疗。结果:对比两组患者在停止用药14d后的复诊结果。其中BV+VVC感染观察组有效率为85.7%,对照组为66.7%;BV+TV感染观察组的治疗有效率为94.4%,对照组为64.7%;而TV+VVC感染观察组患者的治疗有效率为91.0%,对照组为72.7%;BV+VVC+TV混合感染观察组治疗有效率为92.3%,对照组为50.0%。两组患者在接受治疗后的30d复诊结果,其中BV+VVC感染观察组有效率为89.3%,对照组为50.0%;BV+TV感染观察组的治疗有效率为100%,对照组为41.2%;而TV+VVC感染观察组患者的治疗有效率为100.0%,对照组为50.0%;BV+VVC+TV混合感染观察组治疗有效率为92.3%,对照组为41.7%。对比观察组和对照组患者药物不良反应,其中观察组总体不良反应发病率为8.6%;对照组总不良反应发生率为22.9%,对比有显著性。结论:妇肤康喷雾剂能够较好治疗混合性阴道感染,不破坏阴道弱酸性环境,安全性高、复发率低,便于使用。 Objectives:To observe the clinical efficacy of Fufukang spray treatment of mixed vaginal infec-tion.Methods:140 patients with mixed vaginal infections from March 2009 to March 2014 were selected and ran-domly divided into observation group and control group,in which the observation group were treated with nystatin joint Fufukang spray treatment and the control group received conventional treatment of metronidazole and nystatin. Results:The results of subsequent visits on the 14th day after terminating treatment of both groups were compared. The BV +VVC infection treatment rate in the observation group and control group was 85.7% and 66.7% respec-tively;the BV +TV infection treatment rate in the observation group and control group was 94.4% and 64.7% re-spectively;the TV + VVC infection treatment rate in the observation group and control group was 91.0 % and 72.7% respectively;the BV + VVC + TV mixed infection treatment rate in the observation group and control group was 92.3 % and 50.0% respectively.According to the results of subsequent visits on the 30th day after termi-nating treatment,the BV +VVC infection treatment rate in the observation group and control group was 89.3% and 50% respectively;the BV +TV infection treatment rate in the observation group and control group was 100% and 41.2% respectively;the TV +VVC infection treatment rate in the observation group and control group was 100%and 50% respectively;the BV +VVC +TV mixed infection treatment in the observation group and control group was 92.3 % and 41.7 % respectively.The overall incidence of adverse reactions in the observation group and control group was 8.6% and 22.9% respectively,with significant difference.Conclusions:Fufukang sprays can treat mixed vaginal infections while does not destroy the weak acid environment in vagina,which is safe and easy access with low recurrence rate.
出处 《中国性科学》 2015年第9期43-46,共4页 Chinese Journal of Human Sexuality
关键词 妇肤康喷雾剂 混合性阴道感染 临床研究 Fufukang sprays Mixed vaginal infections Clinical study
  • 相关文献

参考文献15

  • 1张小勤.妇肤康喷雾剂在霉菌性阴道炎治疗中的疗效观察.医学信息,2013(28):229-230.
  • 2王赞.硝呋太尔制霉素阴道软胶囊治疗混合性阴道感染的临床疗效[J].中国现代药物应用,2014,8(4):142-143. 被引量:5
  • 3李菊,赵文赫.硝呋太尔制霉素阴道软胶囊治疗VVC与BV混合感染44例[J].陕西医学杂志,2013,42(2):239-240. 被引量:18
  • 4雷鸣瑶.女性阴道混合性感染临床分析[J].临床合理用药杂志,2013,6(30):10-11. 被引量:3
  • 5Spear GT,Gilbert D,Sikaroodi,et al.Identification of rhesus macaque genital microbiota by 16S pyrosequencing shows similarities to human bacterial vaginosis:implications for use as an animal model for HIV vaginal infection.AIDS Research and Human Retroviruses,2010,26(2):193-200.
  • 6Kenney J,Singer R,Derby N,et al.A single dose of a MIV-150/zinc acetate gel provides 24h of protection against vaginal simian human immunodeficiency virus reverse transcriptase infection,with more limited protection rectally 8-24h after gel use.AIDS Research and Human Retroviruses,2012,28(11):1476-1484.
  • 7Dobard,Charles,Sharma,et al.Durable protection from vaginal simian-human immunodeficiency virus infection in macaques by tenofovir gel and its relationship to drug levels in tissue.Journal of Virology,2012,86(2):718-725.
  • 8Donders G,Bellen G,Ausma J,et al.The effect of antifungal treatment on the vaginal flora of women with vulvo-vaginal yeast infection with or without bacterial vaginosis.European Journal of Clinical Microbiology and Infectious Diseases,2011,30(1):59-63.
  • 9D’Souza G,Burk RD,Zhong Y,et al.Cervicovaginal human papillomavirus(HPV)-infection before and after hysterectomy:Evidence of different tissue tropism for oncogenic and nononcogenic HPV types in a cohort of HIV-positive and HIV-negative women.International Journal of Cancer,2012,131(6):1472-1478.
  • 10喻蓉.用妇肤康喷雾剂治疗老年性阴道炎43例的疗效观察[J].求医问药(下半月),2013(10):318-319. 被引量:10

二级参考文献44

  • 1陈海霞.乳杆菌治疗细菌性阴道病的临床疗效观察[J].中国微生态学杂志,2004,16(6):363-363. 被引量:2
  • 2辜学敏,李洁明.爱杰特凝胶治疗阴道炎100例疗效观察[J].实用医学杂志,2006,22(3):336-337. 被引量:1
  • 3Faro S.Vaginitis:differential diagnosis and management[M].London:Parthenon Publishing,2004:45-65.
  • 4Mohanty S,Xess I,Hasan F,et al.Prevalence & susceptibility to fluconazole of Candida Species Causing Vulvovaginitis[J].Indian J Med Res,2007,126(3):216-219.
  • 5Amsel R,Totten PA,Spiegel CA,et al.Nonspecific vaginitis.Diagnostic criteria and microbial and epidemiological associations.Am J Med,1983,74:14-22.
  • 6Donders GG,Vereecken A,Bosmans E,et al.Definition of a type of abnormal vaginal flora that is distinct from bacterial vaginosis:aerobic vaginitis.BJOG,2002,109:34-43.
  • 7Cibley LJ,Cibley LJ.Cytolytic vaginosis.Am J Obstet Gynecol,1991,165:1245-1249.
  • 8Gardner HL.Desquamative inflammatory vaginitis:a newly defined entity.Am J Obstet Gynecol,1968,102:1102-1105.
  • 9Cepicky P,Malina J,Líbalová Z,et al."Mixed" and "miscellaneous" vulvovaginitis:diagnostics and therapy of vaginal administration of nystatin and nifuratel.Ceska Gynekol,2005,70:232-237.
  • 10Anderson MR,Klink K,Cohrssen A.Evaluation of vaginal complaints.JAMA,2004,291:1368-1379.

共引文献193

同被引文献66

引证文献6

二级引证文献11

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部